CVS Health Corporation (CVS) Shares Bought by Sentry Investments Corp.
Sentry Investments Corp. increased its holdings in shares of CVS Health Corporation (NYSE:CVS) by 1.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,519,100 shares of the pharmacy operator’s stock after acquiring an additional 57,100 shares during the quarter. CVS Health Corporation comprises 3.2% of Sentry Investments Corp.’s investment portfolio, making the stock its 4th biggest position. Sentry Investments Corp. owned about 0.54% of CVS Health Corporation worth $444,067,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Gemmer Asset Management LLC boosted its position in CVS Health Corporation by 15.3% during the second quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock worth $121,000 after acquiring an additional 200 shares during the last quarter. TB Alternative Assets Ltd. acquired a new position in CVS Health Corporation during the second quarter worth about $121,000. SRS Capital Advisors Inc. boosted its position in CVS Health Corporation by 48.2% during the first quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock worth $177,000 after acquiring an additional 734 shares during the last quarter. Grace & White Inc. NY acquired a new position in CVS Health Corporation during the second quarter worth about $199,000. Finally, Nadler Financial Group Inc. acquired a new position in CVS Health Corporation during the second quarter worth about $202,000. Hedge funds and other institutional investors own 82.04% of the company’s stock.
Shares of CVS Health Corporation (NYSE CVS) opened at $70.99 on Monday. The firm has a market cap of $71,912.30, a price-to-earnings ratio of 12.43, a P/E/G ratio of 1.22 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. CVS Health Corporation has a 52 week low of $66.45 and a 52 week high of $84.72.
CVS Health Corporation (NYSE:CVS) last announced its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 EPS for the quarter, topping the Zacks’ consensus estimate of $1.49 by $0.01. The company had revenue of $46.18 billion during the quarter, compared to the consensus estimate of $46.17 billion. CVS Health Corporation had a net margin of 2.77% and a return on equity of 16.96%. CVS Health Corporation’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.64 EPS. analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were given a dividend of $0.50 per share. The ex-dividend date was Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.82%. CVS Health Corporation’s payout ratio is currently 41.32%.
In other news, CFO David M. Denton sold 237,078 shares of the stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $79.65, for a total value of $18,883,262.70. Following the completion of the transaction, the chief financial officer now owns 141,096 shares in the company, valued at approximately $11,238,296.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, COO Jonathan C. Roberts sold 85,743 shares of the stock in a transaction dated Monday, September 18th. The shares were sold at an average price of $83.14, for a total transaction of $7,128,673.02. Following the completion of the transaction, the chief operating officer now owns 119,555 shares of the company’s stock, valued at approximately $9,939,802.70. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is owned by insiders.
COPYRIGHT VIOLATION WARNING: This news story was originally published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/11/13/cvs-health-corporation-cvs-shares-bought-by-sentry-investments-corp.html.
A number of research firms recently weighed in on CVS. Jefferies Group LLC lowered their price target on shares of CVS Health Corporation from $86.00 to $76.00 and set a “hold” rating on the stock in a research report on Tuesday, November 7th. Leerink Swann reiterated an “outperform” rating and issued a $85.00 target price (down from $90.00) on shares of CVS Health Corporation in a report on Tuesday, November 7th. Loop Capital decreased their target price on shares of CVS Health Corporation from $83.00 to $73.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. BidaskClub upgraded shares of CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 2nd. Finally, Needham & Company LLC upgraded shares of CVS Health Corporation from a “hold” rating to a “buy” rating and boosted their target price for the company from $69.02 to $79.00 in a report on Friday. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and fourteen have assigned a buy rating to the stock. The stock currently has an average rating of “Buy” and an average target price of $85.82.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS).
Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.